Picture of Inogen logo

INGN — Inogen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Inogen Inc expected to post a loss of 61 cents a share - Earnings Preview

* Inogen Inc  INGN.OQ   INGN.O  is expected to show a fall
in
quarterly revenue when it reports  results on February 25 for
the period ending December 31 2024
    * The Goleta California-based  company is expected to report
a
2.6% decrease in revenue to $73.91 million from $75.9 million a
year ago, according to the mean estimate from 4 analysts, based
on LSEG data.The company's guidance on January 13 2025, for the
period ended December 31, was for revenue between $79.00 million
and $80.00 million.
    * ​LSEG's mean analyst estimate for Inogen Inc is for a loss
of 61
cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Inogen Inc
is
$10.00​, below​ its last closing price of $10.28. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  -0.50       -0.49      -0.25     Beat    49.5
 Jun. 30 2024  -0.55       -0.54      -0.24     Beat    56
 Mar. 31 2024  -0.76       -0.76      -0.62     Beat    18.2​
 Dec. 31 2023  -0.61       -0.62      -1.14     Missed  -82.4
 ​​Sep.        -0.45       -0.49      -0.55     Missed  -11.7
 30 2023                                                
 Jun. 30 2023  -0.61       -0.59      -0.42     Beat    29.3​
 Mar. 31 2023  -0.82       -0.78      -0.88     Missed  -12.8
 Dec. 31 2022  -0.56       -0.57      -0.20     Beat    65.2
 This summary was machine generated February 21 at 21:47 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Inogen

See all news